Page last updated: 2024-08-23

lovastatin and Adenocarcinoma, Follicular

lovastatin has been researched along with Adenocarcinoma, Follicular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engel, E; Fröhlich, E; Wahl, R1

Other Studies

1 other study(ies) available for lovastatin and Adenocarcinoma, Follicular

ArticleYear
Decrease in dipeptidyl peptidase IV activity is linked to the efficacy of differentiating compounds in follicular thyroid carcinoma cell lines.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2011, Volume: 43, Issue:5

    Topics: Adenocarcinoma, Follicular; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Dipeptidyl Peptidase 4; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Lovastatin; Thyroid Neoplasms; Vitamin A

2011